Vesalius
Trial Completed
-
Adelaide SA | Goolwa SA
Effect of Evolocumab on CV events in patients with CV risk but no prior MI or CVA.
- Self-administered fortnightly injections
Requirements
- Age > 50 years
- Elevated LDL
- Evidence of CV risk
Outpatient Visit
- Clinic visits every 3 months
Payment / Remuneration
- Reimbursed for travel